Aaron I. Davis, Director, 10% Owner at Odonate Therapeutics, Inc. (ODT), bought 53,648 shares at $14.72 ($790K) on 2018-10-24, disclosed to the SEC on 2018-10-26.
Open-market purchase of $790k ODT by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $14.72 | 26,824 | $395K | 50.0% |
| 2 | $14.72 | 26,824 | $395K | 50.0% |
| Total | $14.72 avg | 53,648 | $790K | 100% |
| Filing → |
| TYRA | SELL | 2023-02-13 | $4.4M | — | Filing → |
| RAIN | BUY | 2022-11-08 | $11.3M | — | Filing → |
| ITOS | SELL | 2022-05-11 | $20.2M | — | Filing → |